These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 32116112)

  • 1. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
    Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
    Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARĪ±/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.
    Wang Y; Gao R; Li J; Tang S; Li S; Tong Q; Mao Y
    Aging (Albany NY); 2020 May; 12(10):9793-9806. PubMed ID: 32464601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622.
    Zou H; Xu X; Luo L; Zhang Y; Luo L; Yao Y; Xiang G; Huang X; Wang G
    Cell Cycle; 2019 Oct; 18(19):2398-2413. PubMed ID: 31095447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of circular RNA circ_0008450 predicts dismal prognosis in hepatocellular carcinoma and regulates cell proliferation, apoptosis, and invasion via sponging miR-548p.
    Zhang J; Chang Y; Xu L; Qin L
    J Cell Biochem; 2019 Jun; 120(6):9487-9494. PubMed ID: 30556306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Liu Y; Luo X; Chen W; Dong Z; Cheng T; Chen L; Ju L; Cai W; Bian Z
    Cell Cycle; 2024 Mar; 23(5):519-536. PubMed ID: 38684479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
    Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.
    Cao S; Wang G; Wang J; Li C; Zhang L
    Immunol Cell Biol; 2019 Feb; 97(2):218-228. PubMed ID: 30302825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307.
    Wang YG; Wang T; Ding M; Xiang SH; Shi M; Zhai B
    Cancer Lett; 2019 Sep; 460():128-138. PubMed ID: 31207319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
    Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
    J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1.
    Wu S; Tang T; Zhou H; Huang J; Kang X; Zhang J
    Cancer Biol Ther; 2023 Dec; 24(1):2256951. PubMed ID: 37773733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
    Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
    Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells.
    Chen KH; Pan JF; Chen ZX; Pan D; Gao T; Huang M; Huang JN
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4161-4171. PubMed ID: 32373952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA hsa_circ_0051040 Promotes Hepatocellular Carcinoma Progression by Sponging miR-569 and Regulating ITGAV Expression.
    Ju L; Yao M; Lu R; Cao Y; Wang H; Yuan L; Xiao F; Shao J; Cai W; Chen L; Bian Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.